Abstract
No public abstract is available from the verified source records.
Dawn N Waterhouse, Marcel B Bally
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local citing links have been materialized yet.
10.1038/nature03794
10.1038/nature03794
10.1001/jama.1984.03340410063036
10.1001/jama.1984.03340410063036
Unresolved referenced work
1967
Unresolved referenced work
1974
10.1177/104345429401100406
10.1177/104345429401100406
10.1001/archneur.1967.00470220041005
10.1001/archneur.1967.00470220041005
10.3109/10611869609015970
10.3109/10611869609015970
Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.
10.1016/s0031-6997(24)01426-1 · 1999
10.1056/nejm197111182852108
10.1056/nejm197111182852108
10.1038/nrc1093
10.1038/nrc1093
Current development status of small-molecule vascular disrupting agents.
2006
Unresolved referenced work
2006
10.1016/j.bmc.2005.12.033
10.1016/j.bmc.2005.12.033
10.1039/b505955k
10.1039/b505955k
10.1158/1078-0432.ccr-04-1434
10.1158/1078-0432.ccr-04-1434
10.1007/s11095-005-5646-0
10.1007/s11095-005-5646-0
10.1208/pt070232
10.1208/pt070232
10.1097/00006676-200604000-00010
10.1097/00006676-200604000-00010
10.1080/10409230091169186
10.1080/10409230091169186
10.1007/s00280-005-0145-x
10.1007/s00280-005-0145-x
10.2165/00003495-199700544-00005
10.2165/00003495-199700544-00005
10.1002/1097-0142(19840915)54:13.0.co;2-e
10.1002/1097-0142(19840915)54:1<1155::aid-cncr2820541311>3.0.co;2-e
10.3109/07357909309020256
10.3109/07357909309020256
Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.
2001
10.2174/156720105774370294
10.2174/156720105774370294
10.1158/1535-7163.mct-06-0118
10.1158/1535-7163.mct-06-0118
10.1038/nrd2089
10.1038/nrd2089
10.1634/theoncologist.11-7-704
10.1634/theoncologist.11-7-704
10.1158/1078-0432.ccr-06-0095
10.1158/1078-0432.ccr-06-0095
No additional external references are available.